KIND: Communication Disorders
Course

KIND: Communication Disorders

Time limit: 360 days

$150 Enroll

Full course description

The KIND Communication Disorders Chapter provides a thorough exploration of communication disorders, addressing foundational topics such as normal language development and epidemiology, and advancing through specific disorders like speech sound and fluency issues. Key topics include red flags for language disorders, bilingual assessment considerations, and strategies for optimizing language development. Tailored for allied and medical professionals, the course emphasizes practical application, culminating in an interactive case scenario that allows learners to apply their skills in assessing and managing communication disorders in real-world settings.

 

The Communication Disorders Chapter spans 20 topics across five levels of instruction. Levels 1 and 2 provide foundational knowledge beneficial for medical professionals and allied professionals, including educators, social workers, therapists, and psychologists. Levels 3 to 5 shift to a more clinical focus, offering advanced insights geared toward medical doctors and sub-specialists.

The table below outlines the complete chapter content.


Chapter Editor

 

Dr. Mary L. O'Connor Leppert, MD, BCh is a neurodevelopmental pediatrician in the Department of Neurology and Developmental Medicine at Kennedy Krieger Institute.  Dr. Leppert is also the Division Director of Developmental Pediatrics in the Department of Pediatrics at Johns Hopkins University School of Medicine.  Dr. Leppert's focus is on the education on neurodevelopmental disorders. She is the founder and director of the Teaching Excellence in Neuro Development (TEND) program, the director of Kennedy Krieger Project ECHO and is the chief editor of the Kennedy Krieger Instruction in Neurodevelopmental Disorders (KIND) curriculum.  In addition, Dr. Leppert is an associate professor of pediatrics at the Johns Hopkins University School of Medicine.


Content, Featured Experts, and Learner Groups

 

Level

Neurodevelopmental Topic Content

Featured Expert

Learner Group(s)

Level 1

1.1 Communication Disorders and Vocabulary

Mary Leppert, MB, BCH 

Allied professionals

Medical Professionals

Sub-Specialist Professionals

1.2 Epidemiology of Communication Disorders

Mary Leppert, MB, BCH 

1.3 Normal Language Development

Mihee Bay, MD

Level 2

2.1 Red Flags for Language Disorders

Mihee Bay, MD

Allied professionals

Medical Professionals

Sub-Specialist Professionals

2.2 Speech Sound Disorders Defined

Wendy A. Jennejahn, M.S., CCC-SLP  

2.3 Mixed Receptive and Expressive Disorders

Mary Leppert, MB BCH 

2.4 Expressive Language Disorders

Mary Leppert, MB BCH

2.5 Social Pragmatic Communication Disorder Defined

Kate Smidl, MS, CCC-SLP 

2.6 Fluency Disorders Defined

Kate Smidl, MS, CCC-SLP 

Level 3

3.1 Considerations in Taking a History of Language Impairment

Mary Leppert, MB BCH 

Medical Professionals

Sub-Specialist Professionals

3.2 Oral Motor Evaluation in a Child with Speech Sound Disorder

Wendy A. Jennejahn, M.S., CCC-SLP  

3.3 Office Assessment of Speech and Language

Mary Leppert, MB BCH

3.4 Language Assessment Considerations in Simultaneously Bilingual Children

Amber Surveski, MS, CCC-SLP

3.5 Speech and Language Pathology Assessment Measures

Kate Smidl, MS, CCC-SLP

3.6 Social Pragmatic Language Assessment

Kate Smidl, MS, CCC-SLP

Level 4

4.1 Optimizing Language Development

Mary Leppert, MB BCH 

Medical Professionals

Sub-Specialist Professionals

4.2 Prescribing Speech and Language Services

Amber Surveski, MS, CCC-SLP

4.3 Social Pragmatic Communication Training

Kate Smidl, MS, CCC-SLP

4.4 Disorders Associated with Developmental Language Disorder (DLD)

Mary Leppert, MB BCH 

Level 5

5.1 Outcomes of Speech and Language Disorders

Mary Leppert, MB BCH 

Medical Professionals

Sub-Specialist Professionals

Case Study

Interactive Case Scenario

N/A

All Learners

What is the KIND Curriculum?

 

 


 

Terms of Use & Privacy Policy

The Terms of Use and Privacy Policy set forth on the Kennedy Krieger Institute website apply to any and all uses of and access to this site and the content found here.


The learning materials contained in the KIND Curriculum (“Learning Materials”) include publicly available medical evidence, expert opinion, and the experiential knowledge of the subject matter experts identified in the KIND Curriculum.

 

The Learning Materials are intended only to provide general information and need to be adapted for individualized patient care based on each practitioners’ professional judgment, unique patient circumstances, and other pertinent factors. The Learning Materials are not intended to constitute general medical advice or treatment or advice or treatment for any particular patient. The Learning Materials are not intended to create a doctor-patient relationship between/among Kennedy Krieger Institute, its physicians and individual patients or their family members or caregivers. Kennedy Krieger Institute makes no warranty, expressed or implied, with respect to the currency, completeness, applicability, or accuracy of the Learning Materials.

To the extent that the Learning Materials include information regarding drug dosing, every effort will be made to identify when drug or medical device information included in the Learning Materials is not in agreement with FDA approval or guidance. However, it is the responsibility of the practitioner to ascertain FDA dosing recommendations and approval status of prescribed drugs and devices in their clinical practices. 


Kennedy Krieger Institute and its employees and agents are not responsible for errors or omissions in the Learning Materials.  Each professional practitioner caring for a patient is solely and exclusively responsible for the patient care of such patient.

 

The Learning Materials are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Learning Materials may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.